Sanofi (SNY) Receivables - Net (2016 - 2025)
Sanofi (SNY) has disclosed Receivables - Net for 11 consecutive years, with $9.8 billion as the latest value for Q4 2025.
- Quarterly Receivables - Net rose 19.33% to $9.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.8 billion through Dec 2025, up 19.33% year-over-year, with the annual reading at $9.5 billion for FY2025, 14.35% up from the prior year.
- Receivables - Net hit $9.8 billion in Q4 2025 for Sanofi, up from $8.2 billion in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $9.8 billion in Q4 2025 to a low of $8.2 billion in Q4 2024.
- Historically, Receivables - Net has averaged $8.9 billion across 5 years, with a median of $8.7 billion in 2021.
- Biggest five-year swings in Receivables - Net: dropped 9.59% in 2024 and later rose 19.33% in 2025.
- Year by year, Receivables - Net stood at $8.7 billion in 2021, then dropped by 0.73% to $8.6 billion in 2022, then rose by 5.57% to $9.1 billion in 2023, then decreased by 9.59% to $8.2 billion in 2024, then grew by 19.33% to $9.8 billion in 2025.
- Business Quant data shows Receivables - Net for SNY at $9.8 billion in Q4 2025, $8.2 billion in Q4 2024, and $9.1 billion in Q4 2023.